We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. While several trials of angiotensin receptor blockers in ...

In a recent study published in the BMJ, researchers conducted a phase three, multicenter, randomized controlled trial to evaluate the effect of using angiotensin receptor blockers that disrupt the ...

SaveHealth reports on 10 hypertension medications, their classifications, effectiveness, side effects, and safety in managing ...

Scientists have discovered a new generation of angiotensin receptor blockers that may be used to treat coronavirus disease 2019 (COVID-19). In silico docking and molecular dynamics studies have shown ...

Role of the RAAS in the Pathophysiology of Heart Failure ACE inhibitors have no effect on angiotensin II formed by alternate pathways. In contrast, ARBs would be expected to inhibit the biologic ...

Losartan may help stop the epileptic process in certain patients with hypertension. An observational study that analyzed medical records of 2.26 million patients with hypertension found a roughly 30% ...

Please provide your email address to receive an email when new articles are posted on . Patients with albuminuric chronic kidney disease without diabetes can experience a significantly increased ...

Older patients with hypertension are often inadequately treated due to misconceptions regarding reasonable goal blood pressures or concerns about treatment side effects. Adequately treating ...

A phase 1 multiple-ascending dose study to evaluate the safety and tolerability of XmAb23104 (PD-1 x ICOS) in subjects with selected advanced solid tumors (DUET-3). This is an ASCO Meeting Abstract ...

Researchers found that the incidence of epilepsy was reduced with use of ARBs vs ACEs, β-blockers, and a combination of other antihypertensive classes. HealthDay News — For patients with hypertension, ...

The prognostic impact of KRAS mutation in colorectal cancer patients: A meta-analysis of phase III clinical trials. This is an ASCO Meeting Abstract from the 2014 ASCO Annual Meeting I. This abstract ...